FGFR1 and glioblastoma: Based on the evidence implicating FGFR1 as a GSC regulator, it is further tempting to speculate whether the targeted inhibition of FGFR1 in combination with conventional chemo/radiotherapy could prevent or delay recurrence in GBM.